March 18 (Bloomberg) — Chugai Pharmaceutical Co. defended its Actemra arthritis drug after a report linking the medication to deaths sent the stock plunging the most this year.
Arthritis Information
March 18 (Bloomberg) — Chugai Pharmaceutical Co. defended its Actemra arthritis drug after a report linking the medication to deaths sent the stock plunging the most this year.